{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:18:27Z","timestamp":1791497907384,"version":"4.3.4"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:00:00Z","timestamp":1601078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an unprecedented challenge for health care and the global economy. Repurposing drugs that have shown promise in inhibiting other viral infections could allow for more rapid dispensation of urgently needed therapeutics. The Spike protein of SARS-CoV-2 is extensively glycosylated with 22 occupied N glycan sites and is required for viral entry. In other glycosylated viral proteins, glycosylation is required for interaction with calnexin and chaperone-mediated folding in the endoplasmic reticulum, and prevention of this interaction leads to unfolded viral proteins and thus inhibits viral replication. As such, we investigated two iminosugars, celgosivir, a prodrug of castanospermine, and UV-4, or N-(9-methoxynonyl)-1-deoxynojirimycin, a deoxynojirimycin derivative. Iminosugars are known inhibitors of the \u03b1-glucosidase I and II enzymes and were effective at inhibiting authentic SARS-CoV-2 viral replication in a cell culture system. Celgosivir prevented SARS-CoV-2-induced cell death and reduced viral replication and Spike protein levels in a dose-dependent manner in culture with Vero E6 cells. Castanospermine, the active form of celgosivir, was also able to inhibit SARS-CoV-2, confirming the canonical castanospermine mechanism of action of celgosivir. The monocyclic UV-4 also prevented SARS-CoV-2-induced death and reduced viral replication after 24\u00a0h of treatment, although the reduction in viral copies was lost after 48\u00a0h. Our findings suggest that iminosugars should be urgently investigated as potential SARS-CoV-2 inhibitors.<\/jats:p>","DOI":"10.1093\/glycob\/cwaa091","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T19:15:50Z","timestamp":1600974950000},"page":"378-384","source":"Crossref","is-referenced-by-count":67,"title":["The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication"],"prefix":"10.1093","volume":"31","author":[{"given":"Elizabeth C","family":"Clarke","sequence":"first","affiliation":[{"name":"MSC10 5550 Department of Internal Medicine, 1 University of New Mexico Albuquerque, NM, 87131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Nofchissey","sequence":"additional","affiliation":[{"name":"MSC10 5550 Department of Internal Medicine, 1 University of New Mexico Albuquerque, NM, 87131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Ye","sequence":"additional","affiliation":[{"name":"MSC10 5550 Department of Internal Medicine, 1 University of New Mexico Albuquerque, NM, 87131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1985-751X","authenticated-orcid":false,"given":"Steven B","family":"Bradfute","sequence":"additional","affiliation":[{"name":"MSC10 5550 Department of Internal Medicine, 1 University of New Mexico Albuquerque, NM, 87131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,26]]},"reference":[{"issue":"2","key":"2021050310570273700_ref1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1042\/BST20160182","article-title":"Iminosugar antivirals: the therapeutic sweet spot","volume":"45","author":"Alonzi","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"2021050310570273700_ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00531","article-title":"Iminosugars with endoplasmic reticulum \u03b1-glucosidase inhibitor activity inhibit ZIKV replication and reverse cytopathogenicity in vitro","volume":"11","author":"Bhushan","year":"2020","journal-title":"Front Microbiol"},{"key":"2021050310570273700_ref3","doi-asserted-by":"publisher","DOI":"10.1002\/9780470517437","volume-title":"Iminosugars","author":"Compain","year":"2007"},{"issue":"21","key":"2021050310570273700_ref4","doi-asserted-by":"publisher","first-page":"11745","DOI":"10.1128\/JVI.01250-12","article-title":"Monitoring of S protein maturation in the endoplasmic reticulum by calnexin is important for the infectivity of severe acute respiratory syndrome coronavirus","volume":"86","author":"Fukushi","year":"2012","journal-title":"J Virol"},{"issue":"7816","key":"2021050310570273700_ref5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"2","key":"2021050310570273700_ref6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"20","key":"2021050310570273700_ref7","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1016\/0040-4039(90)80159-J","article-title":"Synthesis of potent anti-HIV agents: esters of castanospermine","volume":"31","author":"Liu","year":"1990","journal-title":"Tetrahedron Lett"},{"issue":"8","key":"2021050310570273700_ref8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","article-title":"Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"14","author":"Low","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2021050310570273700_ref9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-981-10-8727-1_20","article-title":"Mechanisms of antiviral activity of iminosugars against dengue virus","volume":"1062","author":"Miller","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"2021050310570273700_ref10a","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/glycob\/cwz029","article-title":"Characterizing the selectivity of ER \u03b1-glucosidase inhibitors","volume":"29","year":"2019","journal-title":"Glycobiology"},{"issue":"1","key":"2021050310570273700_ref10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.antiviral.2013.01.004","article-title":"An iminosugar with potent inhibition of dengue virus infection in vivo","volume":"98","author":"Perry","year":"2013","journal-title":"Antiviral Res"},{"issue":"3","key":"2021050310570273700_ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004524","article-title":"Iminosugars inhibit dengue virus production via inhibition of ER alpha-glucosidases\u2014not glycolipid processing enzymes","volume":"10","author":"Sayce","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"2021050310570273700_ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004851","article-title":"Extended evaluation of virological, immunological and pharmacokinetic endpoints of CELADEN: a randomized, placebo-controlled trial of celgosivir in dengue fever patients","volume":"10","author":"Sung","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2021050310570273700_ref13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/1040841X.2016.1242868","article-title":"Iminosugars: promising therapeutics for influenza infection","volume":"43","author":"Tyrrell","year":"2017","journal-title":"Crit Rev Microbiol"},{"issue":"8","key":"2021050310570273700_ref14","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1021\/acs.jmedchem.0c00067","article-title":"Targeting endoplasmic reticulum \u03b1-glucosidase I with a single-dose Iminosugar treatment protects against lethal influenza and dengue virus infections","volume":"63","author":"Warfield","year":"2020","journal-title":"J Med Chem"},{"key":"2021050310570273700_ref15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.antiviral.2015.12.008","article-title":"Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: the search for a window for potential therapeutic efficacy","volume":"127","author":"Watanabe","year":"2016","journal-title":"Antiviral Res"},{"issue":"3","key":"2021050310570273700_ref16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/095632020401500304","article-title":"Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C","volume":"15","author":"Whitby","year":"2004","journal-title":"Antivir Chem Chemother"},{"issue":"3","key":"2021050310570273700_ref17a","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1042\/BST20200505","article-title":"\u03b1-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19","volume":"48","year":"2020","journal-title":"Biochemical Society Transactions"},{"issue":"1","key":"2021050310570273700_ref17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/AAC.03999-14","article-title":"Inhibition of Endoplasmic Reticulum-Resident Glucosidases Impairs Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 Spike Protein-Mediated Entry by Altering the Glycan Processing of Angiotensin I-Converting Enzyme 2","volume":"59","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["Glycobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/glycob\/advance-article-pdf\/doi\/10.1093\/glycob\/cwaa091\/34164165\/cwaa091.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/glycob\/article-pdf\/31\/4\/378\/37761638\/cwaa091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/glycob\/article-pdf\/31\/4\/378\/37761638\/cwaa091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T10:59:27Z","timestamp":1620039567000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/glycob\/article\/31\/4\/378\/5911971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,26]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,9,26]]},"published-print":{"date-parts":[[2021,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/glycob\/cwaa091","relation":{},"ISSN":["1460-2423"],"issn-type":[{"value":"1460-2423","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4]]},"published":{"date-parts":[[2020,9,26]]}}}